Forte Biosciences, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Forte Biosciences, Inc. (FBRX) is 189.64M

According to Forte Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 189.64M. This represents a change of -91.30% compared to the average of 2.18B of the last 4 quarters.

Forte Biosciences, Inc. (FBRX) Historical Enterprise Value (quarterly & annually)

How has FBRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Forte Biosciences, Inc. over the last ten years is 471.41M. The current 189.64M Enterprise Value has changed 3.92% with respect to the historical average. Over the past ten years (40 quarters), FBRX's Enterprise Value was at its highest in in the March 2026 quarter at 4.56B. The Enterprise Value was at its lowest in in the September 2022 quarter at -23795655.25.

Forte Biosciences, Inc. (FBRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Forte Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Forte Biosciences, Inc. (FBRX) Average Enterprise Value

How has FBRX Enterprise Value performed in the past?

The current Enterprise Value of Forte Biosciences, Inc. (FBRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Forte Biosciences, Inc. (FBRX) Enterprise Value vs. Peers

How is FBRX’s Enterprise Value compared to its peers?

Forte Biosciences, Inc.’s Enterprise Value is greater than Corbus Pharmaceuticals Holdings, Inc. (78.70M), greater than Applied Therapeutics, Inc. (5.42M), less than Nkarta, Inc. (252.26M), greater than Alector, Inc. (151.88M), greater than Elicio Therapeutics, Inc. (72.87M), greater than PepGen Inc. (98.22M), greater than Cardiff Oncology, Inc. (74.83M), less than Fate Therapeutics, Inc. (280.82M), greater than Actuate Therapeutics Inc (41.80M), greater than Molecular Partners AG (40.49M),

Build a custom stock screener for Forte Biosciences, Inc. (FBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forte Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Forte Biosciences, Inc. (FBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Forte Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.